Portal vein thrombosis (PVT) is an increasingly recognised complication of cirrhosis whose
incidence increases in parallel with the severity of cirrhosis. Several risk factors have been …

Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …

Vascular disorders of the liver, although affecting less than 5/10,000 patients, collectively
account for a number of rare conditions that represent an important health problem …

BACKGROUND & AIMS: Portal vein thrombosis (PVT) is a frequent event in patients with
cirrhosis; it can be treated with anticoagulants, but there are limited data regarding safety …

Objective Limited data are available on the prevention of variceal rebleeding in cirrhotic
patients with portal vein thrombosis (PVT). This study aimed to compare transjugular …

Background & Aims Currently, there are no recommendations in guidelines concerning the
preferred diameter of stents for transjugular intrahepatic portosystemic shunt (TIPS), owing …

Portal vein thrombosis is not uncommon in candidates for transplantation. Partial thrombosis
is more common than complete thrombosis. Despite careful screening at evaluation, a …

Decreased levels of most coagulation factors and thrombocytopenia are the main
haemostatic abnormalities of cirrhosis. As a consequence, this condition was, until recently …

Portal vein thrombosis is an important cause of portal hypertension. PVT occurs in
association with cirrhosis or as a result of malignant invasion by hepatocellular carcinoma or …

Primary damage to hepatic vessels is rare.(i) Hepatic arterial disorders, related mostly to
iatrogenic injury and occasionally to systemic diseases, lead to ischemic cholangiopathy.(ii) …